← Insider buys
ITCI

Intra-Cellular Therapies, Inc.

EVP and Chief Commercial Officer Mark Neumann sold $1.4M of Intra-Cellular Therapies, Inc.

Sold$1,405,047
$75.08Price
18,714Shares
−39%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Fri, Aug 16. Filed Tue, Aug 20, 2:03 PM ET, during the session. Not investment advice.